| Value | ₹300.0 Cr |
|---|---|
| Execution period | Within 4-6 weeks from execution of SPA |
NSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹851.50
- Market cap
- ₹82,877 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 56.9×Sector 52.0×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Annual General Meeting
Max Healthcare shareholders approved special resolutions by postal ballot on 19-Oct-2026. These cover a PRSU scheme for up to 73.5 lakh shares, remuneration for the Chairman and MD, and an alteration of the MoA objects clause.
Max Healthcare Institute Board Meeting Date
Max Healthcare's board meets on 30-Oct-2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Max Healthcare Institute Employee Stock Options
Max Healthcare Institute Limited has instituted the MHIL PRSU Scheme 2026. The scheme covers up to 73.50 lakh equity shares for employee stock-based incentives.
Max Healthcare Institute Annual General Meeting
Max Healthcare Institute announced the postal ballot voting results. Shareholders approved the Performance Linked Restricted Stock Unit Scheme 2026 and other special resolutions.
Max Healthcare Institute Other Announcement
Max Healthcare Institute Limited received an independent ESG rating of '66' from NSE Sustainability Ratings and Analytics. The rating for FY 2025-26 was assigned based on public disclosures.
Max Healthcare Institute Credit Rating
Max Healthcare's CARE AA+ (Stable) long-term and A1+ short-term credit ratings on bank facilities are reaffirmed. No change in rating outlook or amounts.
Other acquisition announcements
All →MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers
Hexaware Technologies Acquisition
Hexaware Technologies announced amalgamation of two wholly owned step-down subsidiaries into its Canadian subsidiary. No cash consideration is involved, and the merger is internal group restructuring.
Zensar Technologies Acquisition
Zensar's board approved merging its wholly owned subsidiary M3bi India into the parent. No consideration or share issuance is involved, and NCLT sanction is pending.
ICICI Lombard General Insurance Company Acquisition Worth ₹172 Cr
ICICI Lombard disclosed that it acquired Rs.172 Crore of State Bank of India shares on October 28, 2026, in its ordinary-course investment function. Its cumulative holding in SBI is now 0.02%.
- Value
- ₹172.0 Cr
- Execution
- Investment made in multiple tranches over a period of time
Emkay Global Financial Services Acquisition Worth ₹30 Cr
Emkay Global will buy Emkay Capital Private Limited for Rs 30 Crore in cash. The related-party deal is expected to complete within 90 days.
- Value
- ₹30.00 Cr
Jindal Stainless Acquisition Worth ₹5.08 Cr
Jindal Stainless acquired an additional ~7% stake in Ampin C&I Three, taking its holding to 24.21%. The cash cost is ~₹5.08 crore for a 40 MW captive solar project.
- Value
- ₹5.08 Cr
- solar captive capacity
- 40.0 MW